Transarterial Chemoembolization for Patients With Hepatocellular Carcinoma Using Miriplatin Without the Need for Hydration
ABSTRACT Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide, with a rising incidence. The most common therapeutic choice for HCC is transarterial chemoembolization (TACE). While the standard protocol of TACE adopts cisplatin, the application of cisplatin needs hydration before...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley
2025-03-01
|
| coleção: | Clinical and Translational Science |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1111/cts.70182 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|